Literature DB >> 17404858

Epidemiology, pathogenesis, and management of Clostridium difficile infection.

Rajaraman Durai1.   

Abstract

Clostridium difficile infection is an important health problem worldwide and leads to increased morbidity and mortality, particularly among the elderly population. Antibiotics, especially those with a broad spectrum, often trigger the infection; hence the use of unnecessary antibiotics should be avoided. Mild to moderate cases respond to metronidazole or vancomycin. Severe cases may require bowel resection. Chronic relapsing cases require a prolonged course of antibiotics, immunoglobulin, probiotics, and, occasionally, feces enema. This review provides a comprehensive update on pathogenesis and management of Clostridium difficile infection for health professionals all over the world.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17404858     DOI: 10.1007/s10620-006-9626-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Colonic abnormalities on CT in adult hospitalized patients with Clostridium difficile colitis: prevalence and significance of findings.

Authors:  Lorraine Ash; Mark E Baker; Charles M O'Malley; Steven M Gordon; Conor P Delaney; Nancy A Obuchowski
Journal:  AJR Am J Roentgenol       Date:  2006-05       Impact factor: 3.959

2.  Antimicrobial susceptibility pattern of Clostridium difficile and its relation to PCR ribotypes in a Swedish university hospital.

Authors:  Olle Aspevall; Annika Lundberg; Lars G Burman; Thomas Akerlund; Bo Svenungsson
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

3.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.

Authors:  Sandra Dial; J A C Delaney; Alan N Barkun; Samy Suissa
Journal:  JAMA       Date:  2005-12-21       Impact factor: 56.272

Review 4.  Ileal perforation secondary to Clostridium difficile enteritis: report of 2 cases.

Authors:  Fernando D Hayetian; Thomas E Read; Marc Brozovich; Robert P Garvin; Philip F Caushaj
Journal:  Arch Surg       Date:  2006-01

5.  Continuation of antibiotics is associated with failure of metronidazole for Clostridium difficile-associated diarrhea.

Authors:  Scott Modena; Satya Gollamudi; Frank Friedenberg
Journal:  J Clin Gastroenterol       Date:  2006-01       Impact factor: 3.062

Review 6.  Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.

Authors:  E Bricker; R Garg; R Nelson; A Loza; T Novak; J Hansen
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

7.  Blood pressure cuffs: friend or foe?

Authors:  N Walker; R Gupta; J Cheesbrough
Journal:  J Hosp Infect       Date:  2006-04-17       Impact factor: 3.926

8.  Inhibition of Clostridium difficile strains by intestinal Lactobacillus species.

Authors:  Paul Naaber; Imbi Smidt; Jelena Štšepetova; Tatjana Brilene; Heidi Annuk; Marika Mikelsaar
Journal:  J Med Microbiol       Date:  2004-06       Impact factor: 2.472

9.  In vitro effects of Clostridium difficile toxins on hepatocytes.

Authors:  J E Mazuski; N Panesar; K Tolman; W E Longo
Journal:  J Surg Res       Date:  1998-10       Impact factor: 2.192

10.  Outcome after colectomy for Clostridium difficile colitis.

Authors:  Walter E Longo; John E Mazuski; Katherine S Virgo; Paul Lee; Anil N Bahadursingh; Frank E Johnson
Journal:  Dis Colon Rectum       Date:  2004-10       Impact factor: 4.585

View more
  5 in total

1.  Comparison of five assays for detection of Clostridium difficile toxin.

Authors:  Kimberle C Chapin; Roberta A Dickenson; Fongman Wu; Sarah B Andrea
Journal:  J Mol Diagn       Date:  2011-04-29       Impact factor: 5.568

2.  Clostridium difficile toxin B differentially affects GPCR-stimulated Ca2+ responses in macrophages: independent roles for Rho and PLA2.

Authors:  Robert A Rebres; Christina Moon; Dianne Decamp; Keng-Mean Lin; Iain D Fraser; Stephen B Milne; Tamara I A Roach; H Alex Brown; William E Seaman
Journal:  J Leukoc Biol       Date:  2010-03-03       Impact factor: 4.962

3.  A Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile Infection.

Authors:  Diane J Schmidt; Gillian Beamer; Jacqueline M Tremblay; Jennifer A Steele; Hyeun Bum Kim; Yaunkai Wang; Michele Debatis; Xingmin Sun; Elena A Kashentseva; Igor P Dmitriev; David T Curiel; Charles B Shoemaker; Saul Tzipori
Journal:  Clin Vaccine Immunol       Date:  2016-09-06

Review 4.  Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread.

Authors:  Archie C A Clements; Ricardo J Soares Magalhães; Andrew J Tatem; David L Paterson; Thomas V Riley
Journal:  Lancet Infect Dis       Date:  2010-06       Impact factor: 25.071

5.  New advances in the treatment of Clostridium difficile infection (CDI).

Authors:  Dennis D Hedge; Joe D Strain; Jodi R Heins; Debra K Farver
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.